The Efficient funding of Chemotherapy (EFC) Review report has been released,
Prof Sanchia Aranda AM was the lead reviewer. The review ‘was looking at the impact and continuing suitability of the current EFC program and associated practices within the supply chain to ensure continuing access to medicines under the EFC Program by examining whether the current EFC Program supports patient access to chemotherapy medicines in an efficient and cost-effective manner. The Government wanted to ensure, through the review process, that the access and funding arrangements for chemotherapy services reflect a transparent, accountable, efficient and equitable model of service.’
The report is 481 pages long. See P15 for the 9 page Executive Summary and P202 for the Findings and recommendations.
Additional information received 14 September:
The addendum to the EFC Review Final Report has now been published (see page 484). The updated version can be accessed on the PBS website.
Any questions on the EFC Review Final Report can be sent to [email protected].
CVA made a submission in 2021 and wrote an article for our July 2021 newsletter, refer P18-19 at https://www.cancervoices.org.au/news/newsletters-archive-pre-may-2022/
